Nvidia collaborating with Alphabet spinoff on drug discovery tech - Bloomberg News
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Nvidia collaborating with Alphabet spinoff on drug discovery tech - Bloomberg News
November 21, 2023 2:26 PM EST
Tigress Financial Partners analyst Ivan Feinseth raised the price target on Alphabet (NASDAQ: GOOGL) to $176.00 while maintaining a Strong Buy rating.
The analyst comments "
We reiterate our Strong Buy rating on GOOGL and increase our 12-month target price to $176 as Search and Advertising revenue will continue to see a reacceleration of growth, and the ongoing integration of AI functionality will continue to drive its leadership position across all key technology trends and business lines. GOOGL should see a significant reacceleration of revenue growth in Q4 of this year and accelerate further in 2024... More
November 21, 2023 10:47 AM EST
Evercore ISI analysts provided their thoughts on what they learned from the Alphabet (NASDAQ: GOOGL)/DOJ trial in a note Tuesday.
The evidentiary portion of the Google vs DOJ legal battle has concluded and, Evercore said that while much of the evidence and testimony was behind closed doors, "there were some interesting details disclosed during the public part of the trial."
During the trial, It was... More
